Ireland - English - HPRA (Health Products Regulatory Authority)

novartis animal health uk ltd - polysulphated glycosaminoglycan - solution for injection - 100 mg/ml - n.s.a.i.d - equine - food

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis animal health uk ltd - polysulphated glycosaminoglycan - solution for injection - 250 mg/ml - n.s.a.i.d - equine - food

European Union - English - EMA (European Medicines Agency)

sanofi b.v. - laronidase - mucopolysaccharidosis i - other alimentary tract and metabolism products, - aldurazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis i (mps i; alpha-l-iduronidase deficiency) to treat the nonneurological manifestations of the disease.

European Union - English - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - idursulfase - mucopolysaccharidosis ii - other alimentary tract and metabolism products, - elaprase is indicated for the long-term treatment of patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). heterozygous females were not studied in the clinical trials.

European Union - English - EMA (European Medicines Agency)

biomarin international limited - galsulfase - mucopolysaccharidosis vi - other alimentary tract and metabolism products, - naglazyme is indicated for long-term enzyme-replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis vi (mps vi; n-acetylgalactosamine-4-sulfatase deficiency; maroteaux-lamy syndrome) (see section 5.1). as for all lysosomal genetic disorders, it is of primary importance, especially in severe forms, to initiate treatment as early as possible, before appearance of non-reversible clinical manifestations of the disease. a key issue is to treat young patients aged

United States - English - NLM (National Library of Medicine)

natural story co.,ltd. - undaria pinnatifida (unii: icv1ok7m1s) (undaria pinnatifida - unii:icv1ok7m1s), hydrolyzed glycosaminoglycans (bovine; 50000 mw) (unii: 997385v0vv) (hydrolyzed glycosaminoglycans (bovine; 50000 mw) - unii:997385v0vv) - special skincare for dry and sensitive skin with abundant moisture and sea algae extract apply proper amount to the skin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

optima consumer health ltd - glucosamine sulfate - oral tablet

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

health+plus ltd - ascorbic acid; glucosamine sulfate - oral tablet

United States - English - NLM (National Library of Medicine)

nidaria technology ltd - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - : ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. uses : ■ apply liberally 15 minutes before sun exposure ■ reapply: after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours ■ sun protection measures- spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: ■ limit time in the sun, especially from 10 a.m.to 2 p.m.■ wear long-sleeve shirts, pants, hats, and sunglasses ■ children under 6 months: ask a doctor. directions

United States - English - NLM (National Library of Medicine)

nidaria technology ltd - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - : ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. uses : ■ apply liberally 15 minutes before sun exposure ■ reapply: after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours ■ sun protection measures- spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: ■ limit time in the sun, especially from 10 a.m.to 2 p.m.■ wear long-sleeve shirts, pants, hats, and sunglasses ■ children under 6 months: ask a doctor. directions